Display options
Cite
Benson KF, Newman RA, Jensen GS. Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves (nae-8(®)). Clin Cosmet Investig Dermatol. 2015;8:239-48doi: 10.2147/CCID.S79871.
Benson, K. F., Newman, R. A., & Jensen, G. S. (2015). Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves (nae-8(®)). Clinical, cosmetic and investigational dermatology, 8239-48. https://doi.org/10.2147/CCID.S79871
Benson, Kathleen F, et al. "Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves (nae-8(®))." Clinical, cosmetic and investigational dermatology vol. 8 (2015): 239-48. doi: https://doi.org/10.2147/CCID.S79871
Benson KF, Newman RA, Jensen GS. Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves (nae-8(®)). Clin Cosmet Investig Dermatol. 2015 May 06;8:239-48. doi: 10.2147/CCID.S79871. eCollection 2015. PMID: 26005354; PMCID: PMC4427598.
Copy Download .nbib Format: NLM
Share it on

Clin Cosmet Investig Dermatol. 2015 May 06;8:239-48. doi: 10.2147/CCID.S79871. eCollection 2015.

Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves (nae-8(®)).

Clinical, cosmetic and investigational dermatology

Kathleen F Benson, Robert A Newman, Gitte S Jensen

Affiliations

  1. NIS Labs, Klamath Falls, Oregon, USA.
  2. University of Texas MD Anderson Cancer Center, Houston, TX, USA ; Nerium Biotechnology, Inc, San Antonio, TX, USA.

PMID: 26005354 PMCID: PMC4427598 DOI: 10.2147/CCID.S79871

Abstract

OBJECTIVE: The goal for this study was to evaluate the effects of an Aloe vera-based Nerium oleander extract (NAE-8(®)), compared to an extract of A. vera gel alone (ALOE), and to an aqueous extract of N. oleander (AQ-NOE) in bioassays pertaining to dermatologic potential with respect to antioxidant protection, anti-inflammatory effects, and cytokine profiles in vitro.

METHODS: Cellular antioxidant protection was evaluated in three separate bioassays: The cellular antioxidant protection of erythrocytes (CAP-e) assay, protection of cellular viability and prevention of apoptosis, and protection of intracellular reduced glutathione levels, where the last two assays were performed using human primary dermal fibroblasts. Reduction of intracellular formation of reactive oxygen species (ROS) was tested using polymorphonuclear cells in the absence and presence of oxidative stress. Changes to cytokine and chemokine profiles when whole blood cells and human primary dermal fibroblasts were exposed to test products were determined using a 40-plex Luminex array as a method for exploring the potential cross-talk between circulating and skin-resident cells.

RESULTS: The NAE-8(®) provided significantly better antioxidant protection in the CAP-e bioassay than AQ-NOE. NAE-8(®) and AQ-NOE both protected cellular viability and intracellular reduced glutathione, and reduced the ROS formation significantly when compared to control cells, both under inflamed and neutral culture conditions. ALOE showed minimal effect in these bioassays. In contrast to the NAE-8(®), the AQ-NOE showed induction of inflammation in the whole blood cultures, as evidenced by the high induction of CD69 expression and secretion of a number of inflammatory cytokines. The treatment of dermal fibroblasts with NAE-8(®) resulted in selective secretion of cytokines involved in collagen and hyaluronan production as well as re-epithelialization during wound healing.

CONCLUSION: NAE-8(®), a novel component of a commercial cosmetic product, showed beneficial antioxidant protection in several cellular models, without the induction of leukocyte activation and secretion of inflammatory cytokines. The biological efficacy of NAE-8(®) was unique from both ALOE and AQ-NOE.

Keywords: CAP-e bioassay; ROS formation; dermal fibroblasts; oxidative damage; safety

References

  1. J Exp Ther Oncol. 2008;7(3):195-205 - PubMed
  2. Molecules. 2012 Nov 01;17 (11):12851-67 - PubMed
  3. Curr Protoc Cytom. 2010 Jul;Chapter 9:Unit 9.35 - PubMed
  4. Folia Histochem Cytobiol. 2011;49(4):664-9 - PubMed
  5. FASEB J. 2013 Sep;27(9):3455-65 - PubMed
  6. Exp Dermatol. 2005 Oct;14(10):736-43 - PubMed
  7. Biochem Pharmacol. 2008 Oct 1;76(7):922-8 - PubMed
  8. J Drugs Dermatol. 2010 Jun;9(6 Suppl):S72-81; quiz s82-3 - PubMed
  9. J Ethnopharmacol. 1995 Dec 1;49(2):57-68 - PubMed
  10. PLoS One. 2013 Oct 25;8(10):e79610 - PubMed
  11. Pharmacogn Rev. 2014 Jul;8(16):156-62 - PubMed
  12. Pharmacogn Mag. 2014 Apr;10(Suppl 2):S392-403 - PubMed
  13. Br J Clin Pharmacol. 2013 May;75(5):1175-88 - PubMed
  14. Molecules. 2008 Aug 08;13(8):1599-616 - PubMed
  15. Fitoterapia. 2013 Jan;84:32-9 - PubMed
  16. Pharm Biol. 2011 Jan;49(1):78-85 - PubMed
  17. J Exp Ther Oncol. 2006;5(3):167-81 - PubMed
  18. Arthritis Rheum. 2006 Jul;54(7):2096-108 - PubMed
  19. J Dermatol Sci. 2013 Jul;71(1):12-21 - PubMed
  20. J Med Food. 2013 Mar;16(3):230-8 - PubMed
  21. J Agric Food Chem. 2008 Sep 24;56(18):8319-25 - PubMed
  22. Clin Toxicol (Phila). 2009 Mar;47(3):206-12 - PubMed
  23. Cell Commun Signal. 2013 Apr 19;11(1):29 - PubMed
  24. Int J Inflam. 2013;2013:780502 - PubMed
  25. J Nat Prod. 2005 Feb;68(2):198-206 - PubMed
  26. Front Pharmacol. 2014 Jul 01;5:151 - PubMed
  27. Antioxid Redox Signal. 2014 Mar 1;20(7):1126-67 - PubMed
  28. J Clin Invest. 1990 Feb;85(2):601-4 - PubMed
  29. Anc Sci Life. 2007 Apr;26(4):24-8 - PubMed
  30. Tissue Eng Part A. 2014 Jan;20(1-2):197-209 - PubMed
  31. J Dermatol. 2007 Sep;34(9):625-34 - PubMed
  32. J Cosmet Dermatol. 2014 Mar;13(1):44-51 - PubMed
  33. Molecules. 2014 May 15;19(5):6202-19 - PubMed

Publication Types